Strategic Lending The firm specializes in discretionary capital deployment across asset-based lending, real estate loans, second-lien loans, lender finance, and project finance, offering quick action on deals from three million to over a hundred million dollars. This presents an opportunity to position complementary financing products or syndication partnerships for large-scale middle-market borrowers.

Private Credit Growth Recent launches of an EM Private Credit strategy and a significant credit line indicate a growth trajectory in private credit capabilities and capital availability. Sales outreach can highlight expanded product suites to institutional clients seeking diversified, non-public market credit exposures.

Biotech and Niche Sectors Active investments in biotech and specialty sectors (Ocular Science and Nurture Life) show comfort with science-driven, regulated industries. This creates opening for targeted solutions in life sciences financing, growth capital, and working capital facilities tailored to R&D and regulatory milestones.

Strategic Partnerships Partnership with Praesidian Capital on acquisitions signals openness to collaboration with other sponsors and funds. Explore co-investment, advisory, and capital markets partnerships to expand deal flow and cross-sell structured credit solutions.

Capital Access & Growth A robust funding profile with a reported revenue range of 100–250 million and a 100 million credit line demonstrates strong liquidity and scalable capital for borrowers. Position credit facilities, advisory services, and financing solutions to mid-market companies seeking growth funding and balance sheet optimization.